miRNA-23b as a biomarker of culture-positive neonatal sepsis

Abstract Background Neonatal sepsis remains an important cause of morbidity and mortality. The ability to quickly and accurately diagnose neonatal sepsis based on clinical assessments and laboratory blood tests remains difficult, where haemoculture is the gold standard for detecting bacterial sepsis...

Full description

Bibliographic Details
Main Authors: Ahlam Fatmi, Sid Ahmed Rebiahi, Nafissa Chabni, Hanane Zerrouki, Hafsa Azzaoui, Yamina Elhabiri, Souheila Benmassour, José Santiago Ibáñez-Cabellos, Mohammed Chems-Eddine Smahi, Mourad Aribi, José Luis García-Giménez, Federico V. Pallardó
Format: Article
Language:English
Published: BMC 2020-10-01
Series:Molecular Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s10020-020-00217-8
id doaj-ea0023e760a24e8a916c1ac5006c0038
record_format Article
spelling doaj-ea0023e760a24e8a916c1ac5006c00382020-11-25T03:40:32ZengBMCMolecular Medicine1076-15511528-36582020-10-012611910.1186/s10020-020-00217-8miRNA-23b as a biomarker of culture-positive neonatal sepsisAhlam Fatmi0Sid Ahmed Rebiahi1Nafissa Chabni2Hanane Zerrouki3Hafsa Azzaoui4Yamina Elhabiri5Souheila Benmassour6José Santiago Ibáñez-Cabellos7Mohammed Chems-Eddine Smahi8Mourad Aribi9José Luis García-Giménez10Federico V. Pallardó11Laboratory of Applied Molecular Biology and ImmunologyLaboratory of Microbiology Applied in Food, Biomedical and EnvironmentFaculty of Medicine, Tlemcen Medical Centre UniversityLaboratory of Microbiology Applied in Food, Biomedical and EnvironmentLaboratory of Applied Molecular Biology and ImmunologyLaboratory of Microbiology Applied in Food, Biomedical and EnvironmentNeonatal Department of Specialized Maternal and Child Hospital of TlemcenCenter for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos IIINeonatal Department of Specialized Maternal and Child Hospital of TlemcenLaboratory of Applied Molecular Biology and ImmunologyCenter for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos IIICenter for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos IIIAbstract Background Neonatal sepsis remains an important cause of morbidity and mortality. The ability to quickly and accurately diagnose neonatal sepsis based on clinical assessments and laboratory blood tests remains difficult, where haemoculture is the gold standard for detecting bacterial sepsis in blood culture. It is also very difficult to study because neonatal samples are lacking. Methods Forty-eight newborns suspected of sepsis admitted to the Neonatology Department of the Mother-Child Specialized Hospital of Tlemcen. From each newborn, a minimum of 1–2 ml of blood was drawn by standard sterile procedures for blood culture. The miRNA-23b level in haemoculture was evaluated by RT-qPCR. Results miR-23b levels increased in premature and full-term newborns in early onset sepsis (p < 0.001 and p < 0.005 respectively), but lowered in late onset sepsis in full-term neonates (p < 0.05) compared to the respective negative controls. miR-23b levels also increased in late sepsis in the negative versus early sepsis negative controls (p < 0.05). miR-23b levels significantly lowered in the newborns who died from both sepsis types (p < 0.0001 and p < 0.05 respectively). In early sepsis, miR-23b and death strongly and negatively correlated (correlation coefficient = − 0.96, p = 0.0019). In late sepsis, miRNA-23b and number of survivors (correlation coefficient = 0.70, p = 0.506) positively correlated. Conclusions Lowering miR-23b levels is an important factor that favours sepsis development, which would confirm their vital protective role, and strongly suggest that they act as a good marker in molecular diagnosis and patient monitoring.http://link.springer.com/article/10.1186/s10020-020-00217-8Early-onset sepsisHaemocultureLate-onset sepsismiR-23bNewborns
collection DOAJ
language English
format Article
sources DOAJ
author Ahlam Fatmi
Sid Ahmed Rebiahi
Nafissa Chabni
Hanane Zerrouki
Hafsa Azzaoui
Yamina Elhabiri
Souheila Benmassour
José Santiago Ibáñez-Cabellos
Mohammed Chems-Eddine Smahi
Mourad Aribi
José Luis García-Giménez
Federico V. Pallardó
spellingShingle Ahlam Fatmi
Sid Ahmed Rebiahi
Nafissa Chabni
Hanane Zerrouki
Hafsa Azzaoui
Yamina Elhabiri
Souheila Benmassour
José Santiago Ibáñez-Cabellos
Mohammed Chems-Eddine Smahi
Mourad Aribi
José Luis García-Giménez
Federico V. Pallardó
miRNA-23b as a biomarker of culture-positive neonatal sepsis
Molecular Medicine
Early-onset sepsis
Haemoculture
Late-onset sepsis
miR-23b
Newborns
author_facet Ahlam Fatmi
Sid Ahmed Rebiahi
Nafissa Chabni
Hanane Zerrouki
Hafsa Azzaoui
Yamina Elhabiri
Souheila Benmassour
José Santiago Ibáñez-Cabellos
Mohammed Chems-Eddine Smahi
Mourad Aribi
José Luis García-Giménez
Federico V. Pallardó
author_sort Ahlam Fatmi
title miRNA-23b as a biomarker of culture-positive neonatal sepsis
title_short miRNA-23b as a biomarker of culture-positive neonatal sepsis
title_full miRNA-23b as a biomarker of culture-positive neonatal sepsis
title_fullStr miRNA-23b as a biomarker of culture-positive neonatal sepsis
title_full_unstemmed miRNA-23b as a biomarker of culture-positive neonatal sepsis
title_sort mirna-23b as a biomarker of culture-positive neonatal sepsis
publisher BMC
series Molecular Medicine
issn 1076-1551
1528-3658
publishDate 2020-10-01
description Abstract Background Neonatal sepsis remains an important cause of morbidity and mortality. The ability to quickly and accurately diagnose neonatal sepsis based on clinical assessments and laboratory blood tests remains difficult, where haemoculture is the gold standard for detecting bacterial sepsis in blood culture. It is also very difficult to study because neonatal samples are lacking. Methods Forty-eight newborns suspected of sepsis admitted to the Neonatology Department of the Mother-Child Specialized Hospital of Tlemcen. From each newborn, a minimum of 1–2 ml of blood was drawn by standard sterile procedures for blood culture. The miRNA-23b level in haemoculture was evaluated by RT-qPCR. Results miR-23b levels increased in premature and full-term newborns in early onset sepsis (p < 0.001 and p < 0.005 respectively), but lowered in late onset sepsis in full-term neonates (p < 0.05) compared to the respective negative controls. miR-23b levels also increased in late sepsis in the negative versus early sepsis negative controls (p < 0.05). miR-23b levels significantly lowered in the newborns who died from both sepsis types (p < 0.0001 and p < 0.05 respectively). In early sepsis, miR-23b and death strongly and negatively correlated (correlation coefficient = − 0.96, p = 0.0019). In late sepsis, miRNA-23b and number of survivors (correlation coefficient = 0.70, p = 0.506) positively correlated. Conclusions Lowering miR-23b levels is an important factor that favours sepsis development, which would confirm their vital protective role, and strongly suggest that they act as a good marker in molecular diagnosis and patient monitoring.
topic Early-onset sepsis
Haemoculture
Late-onset sepsis
miR-23b
Newborns
url http://link.springer.com/article/10.1186/s10020-020-00217-8
work_keys_str_mv AT ahlamfatmi mirna23basabiomarkerofculturepositiveneonatalsepsis
AT sidahmedrebiahi mirna23basabiomarkerofculturepositiveneonatalsepsis
AT nafissachabni mirna23basabiomarkerofculturepositiveneonatalsepsis
AT hananezerrouki mirna23basabiomarkerofculturepositiveneonatalsepsis
AT hafsaazzaoui mirna23basabiomarkerofculturepositiveneonatalsepsis
AT yaminaelhabiri mirna23basabiomarkerofculturepositiveneonatalsepsis
AT souheilabenmassour mirna23basabiomarkerofculturepositiveneonatalsepsis
AT josesantiagoibanezcabellos mirna23basabiomarkerofculturepositiveneonatalsepsis
AT mohammedchemseddinesmahi mirna23basabiomarkerofculturepositiveneonatalsepsis
AT mouradaribi mirna23basabiomarkerofculturepositiveneonatalsepsis
AT joseluisgarciagimenez mirna23basabiomarkerofculturepositiveneonatalsepsis
AT federicovpallardo mirna23basabiomarkerofculturepositiveneonatalsepsis
_version_ 1724534200167563264